Invention Grant
- Patent Title: Beta-lactamase inhibitors
- Patent Title (中): β-内酰胺酶抑制剂
-
Application No.: US14152916Application Date: 2014-01-10
-
Publication No.: US09040504B2Publication Date: 2015-05-26
- Inventor: Christopher J. Burns , Denis Daigle , Bin Liu , Daniel McGarry , Daniel C. Pevear , Robert E. Lee Trout , Randy W. Jackson
- Applicant: VenatoRx Pharmaceuticals, Inc.
- Applicant Address: US PA Malvern
- Assignee: VENATORX PHARMACEUTICALS, INC.
- Current Assignee: VENATORX PHARMACEUTICALS, INC.
- Current Assignee Address: US PA Malvern
- Agency: Wilson Sonsini Goodrich & Rosati
- Main IPC: A61K31/69
- IPC: A61K31/69 ; C07F5/02
Abstract:
Described herein are compounds and compositions that modulate the activity of beta-lactamases. In some embodiments, the compounds described herein inhibit beta-lactamase. In certain embodiments, the compounds described herein are useful in the treatment of bacterial infections.
Public/Granted literature
- US20140194386A1 BETA-LACTAMASE INHIBITORS Public/Granted day:2014-07-10
Information query
